[TOP STORY] Compounded weight-loss drugs raise serious patient safety concerns episode artwork

EPISODE · May 15, 2026 · 7 MIN

[TOP STORY] Compounded weight-loss drugs raise serious patient safety concerns

from Moneyweb@Midday · host Jeremy Maggs

‘I think the main concern with compounded GLP-1s, is that they are not actually assessed or tested by the applicable regulators,’ says Charles Green, healthcare and pharmaceutical expert at Cliffe Dekker Hofmeyr. Moneyweb

‘I think the main concern with compounded GLP-1s, is that they are not actually assessed or tested by the applicable regulators,’ says Charles Green, healthcare and pharmaceutical expert at Cliffe Dekker Hofmeyr.

NOW PLAYING

[TOP STORY] Compounded weight-loss drugs raise serious patient safety concerns

0:00 7:06

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of Moneyweb@Midday?

This episode is 7 minutes long.

When was this Moneyweb@Midday episode published?

This episode was published on May 15, 2026.

What is this episode about?

‘I think the main concern with compounded GLP-1s, is that they are not actually assessed or tested by the applicable regulators,’ says Charles Green, healthcare and pharmaceutical expert at Cliffe Dekker Hofmeyr. Moneyweb

Can I download this Moneyweb@Midday episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!